Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM)
Author(s) -
Hilary J. Powers,
Marilyn Hill,
Sohail Mushtaq,
J. Dainty,
Gosia MajsakNewman,
Elizabeth A. Williams
Publication year - 2011
Publication title -
american journal of clinical nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.608
H-Index - 336
eISSN - 1938-3207
pISSN - 0002-9165
DOI - 10.3945/ajcn.110.008409
Subject(s) - riboflavin , medicine , glutathione reductase , iron deficiency , hemoglobin , placebo , physiology , population , anemia , biology , biochemistry , environmental health , glutathione peroxidase , superoxide dismutase , pathology , oxidative stress , alternative medicine
Moderate riboflavin deficiency is prevalent in certain population groups in affluent countries, but the functional significance of this deficiency is not clear. Studies have indicated a role for riboflavin in the absorption and use of iron.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom